It looks like you're new here. If you want to get involved, click one of these buttons!
He's featured ICMAX (April, 2016) and ICMUX (Mar. 2014), also adding a piece this month about ICMAX.I believe Snowball has written extensively about their virtues.
I'm not that familiar with Intrepid... What is it that you like so much about them, other than performance?As an investor in Oakmark funds for the past 20 years or so, specifically the international funds, I am not happy to hear this. Both OAKIX and OAKEX performance has suffered recently and I am fairly certain that asset bloat with OAKIX at 23.5 billion AUM and OAKEX at 2.4 billion AUM has been a factor on this poor performance. OAKEX in particular hasn't beaten it arrivals for last 1 yr, 3 yr, 5yr , or 10 yr periods. But I believed in the management and stuck with them all the years albeit cutting back on my exposure to OAKEX to about 25% of my original investment. But I think this may finally bring me to sell the remaining holdings in the fund. I originally invested in OAKEX to get small cap international value/blend exposure which was not offered in my 401K selections which only had foreign LC and Emerging Market as investment options. But now I believe their are several better options in the SC International arena. Funds such as ICMIX, ISMRX, and SBSHX all appear to be more compelling options in the international SC area with ICMIX probably being the standout option IMHO. So while I am glad that Oakmark believes that have some many good investment options, I am saying good bye to at least to OAKEX. So be warned since I am planning on selling OAKEX next year they probably return to stellar performance against their peers - just my luck. Disclosure I currently own 4 Oakmark funds - OAKLX, OAKWX, OAKIX, and OAKEX.
"Investors have poured $3 billion into the fund over the past six months and its assets have nearly doubled in the past three years"Meh. Not seeing what size has to do with it, pro or con.
© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla